Individual Differences of Multipotent Mesenchymal Stromal Cells Manifesting in during Interaction with Lymphocytes


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Analysis of changes in lymphocyte subpopulations during co-culturing with multipotent mesenchymal stromal cells (MSC) revealed two distinct MSC groups: one group (A) increased HLA-DR expression on lymphocytes during co-culturing and the other (B) did not change it in comparison with lymphocyte monoculture. In stromal cells interacting with lymphocytes, expression of HLA-DR molecules was initiated, but only in samples that induced enhanced expression on lymphocytes and irrespectively of whether allogeneic or autologous lymphocytes were used for co-culturing with MSC. In group A, the relative expression of IDO1 significantly increased in comparison with group B. The revealed individual differences in MSC can explain why not all MSC samples are effective in the treatment of autoimmune diseases, acute “graft—versus—host” disease, and other pathologies.

About the authors

N. M. Kapranov

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

Yu. O. Davydova

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

I. V. Gal’tseva

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

N. A. Petinati

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

N. V. Sats

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

N. I. Drize

National Research Center for Hematology, Ministry of Health of the Russian Federation

Author for correspondence.
Email: ndrize@yandex.ru
Russian Federation, Moscow

L. A Kuz’mina

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

E. N. Parovichnikova

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

V. G. Savchenko

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies